Barclays PLC Treace Medical Concepts, Inc. Transaction History

Barclays PLC

$357 Billion
Q4 2024

A detailed history of Barclays PLC transactions in Treace Medical Concepts, Inc. stock. As of the latest transaction made, Barclays PLC holds 77,285 shares of TMCI stock, worth $635,282. This represents 0.0% of its overall portfolio holdings.

Number of Shares

77,285

Previous 79,696 3.03%

Holding current value

$635,282

Previous $460,000 17.17%

% of portfolio

0.0%

Previous 0.0%

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 13, 2025	SELL	$4.66 - $8.78 $11,235 - $21,168	-2,411 Reduced 3.03%	77,285 $539,000
Q3 2024 Nov 15, 2024	BUY	$5.01 - $8.45 $310,985 - $524,516	62,073 Added 352.23%	79,696 $460,000
Q2 2024 Aug 14, 2024	SELL	$4.17 - $12.62 $97,673 - $295,598	-23,423 Reduced 57.07%	17,623 $118,000
Q1 2024 May 15, 2024	SELL	$11.48 - $15.86 $347,224 - $479,701	-30,246 Reduced 42.43%	41,046 $535,000
Q4 2023 Feb 15, 2024	BUY	$6.03 - $12.88 $331,360 - $707,781	54,952 Added 336.3%	71,292 $917,000
Q3 2023 Nov 07, 2023	SELL	$12.16 - $24.87 $35,677 - $72,968	-2,934 Reduced 15.22%	16,340 $199,000
Q2 2023 Aug 03, 2023	BUY	$23.91 - $27.81 $15,613 - $18,159	653 Added 3.51%	19,274 $475,000
Q1 2023 May 04, 2023	BUY	$20.23 - $26.22 $195,543 - $253,442	9,666 Added 107.94%	18,621 $479,000
Q4 2022 Feb 13, 2023	BUY	$20.54 - $24.67 $154,892 - $186,036	7,541 Added 533.31%	8,955 $210,000
Q3 2022 Nov 03, 2022	SELL	$14.71 - $24.18 $53,750 - $88,353	-3,654 Reduced 72.1%	1,414 $32,000
Q2 2022 Aug 12, 2022	SELL	$12.93 - $20.29 $42,436 - $66,591	-3,282 Reduced 39.31%	5,068 $73,000
Q1 2022 May 16, 2022	BUY	$16.73 - $21.58 $139,695 - $180,193	8,350 New	8,350 $157,000

Others Institutions Holding TMCI

# of Institutions

139

Shares Held

38.1M

Call Options Held

52K

Put Options Held

19.1K

View Full List

About TREACE MEDICAL CONCEPTS, INC.

Ticker TMCI
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 55,403,300
Market Cap $455M
Description
Treace Medical Concepts, Inc., an orthopedic medical device company, engages in the design, manufacture, and marketing of medical devices for foot and ankle surgeons in the United States. It offers Lapiplasty procedure that allows podiatric surgeons to treat all three dimensions of the bunion, providing patients with a cosmetic and medical impro...

More about TMCI

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Barclays PLC, based on Form 13F filings with the SEC.

News

Stay updated on Barclays PLC with notifications on news.

Account